Groundbreaking Fentanyl Vaccine Enters Human Trials in Historic Step Against Opioid Epidemic
A first-of-its-kind fentanyl vaccine has entered Phase I human trials in the Netherlands, training the immune system to neutralize the deadly opioid before it reaches the brain. The 40-participant trial could lead to a breakthrough treatment for opioid use disorder.